cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of mRNA, Lipid Nanoparticle Based HIV Immunogens

NIH Pandemic-Era Grants

Pandemic Era Grants

2023

↗ Live URL (may be dead)

Document text

Principal Investigator: WENDELL  BERES
Organization: DUKE UNIVERSITY
Fiscal Year: 2023
Award: $6,174,301
Funding agency: National Institute of Allergy and Infectious Diseases

Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS): This program will provide NIAID with a broad and flexible range of capabilities that are required for preclinical and translational development support for promising vaccines and related products for HIV and other candidate agents. Contracts under this program will provide the support and services needed for all stages of process and product development, small-scale production, preclinical testing and documentation leading to Investigational New Drug (IND) submissions for Phase I, II, and III clinical testing. These capabilities will allow NIAID to rapidly and efficiently address development and production gaps. This contract will provide support under Task Area E, Process Development, cGMP Manufacturing and Stability.

Terms: <AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Antigens><Area><Assay><Bioassay><Biologic Assays><Biological Assay><Clinical Evaluation><Clinical Testing><Clinical Trials><Contracting Opportunities><Contracts><Cyclic GMP><Development><Documentation><Encapsulated><Gene Transcription><Generations><Genetic Transcription><Good Manufacturing Process><Good manufacturing practice><Guanosine Cyclic Monophosphate><HIV><Human Immunodeficiency Viruses><In Vitro><Investigational Drugs><Investigational New Drugs><LAV-HTLV-III><Label><Lipids><Lymphadenopathy-Associated Virus><Manufactured Materials><Messenger RNA><NIAID><National Institute of Allergy and Infectious Disease><Phase><Preclinical Testing><Process><Production><RNA Expression><Reaction><Services><Testing><Transcription><Vaccines><Virus-HIV><cGMP><clinical test><develop a vaccine><develop vaccines><development of a vaccine><developmental><flexibility><flexible><immunogen><lipid based nanoparticle><lipid nanoparticle><mRNA><manufacture><pre-clinical><pre-clinical testing><preclinical><product development><programs><research clinical testing><stability testing><vaccine development>